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Background: The effect of fluid balance on outcomes in elderly patients with acute kidney injury (AKI) requiring 
continuous renal-replacement therapy (CRRT) is not explained well. We investigated outcomes according to 
cumulative fluid balance (CFB) in elderly patients with AKI undergoing CRRT. 
Methods: A total of 607 patients aged 65 years or older who started CRRT due to AKI were enrolled and stratified 
into two groups (fluid overload [FO] vs. no fluid overload [NFO]) based on the median CFB value for 72 hours before 
CRRT initiation. Propensity score-matching analysis was performed.
Results: The median age of included patients was 73.0 years and 60.0% of the population was male. The median 72-
hour CFB value was 2,839.0 mL. The overall cumulative survival and 28-day survival rates were lower in the FO group 
than in the NFO group (P < 0.001 for both) and remained so after propensity score-matching. Furthermore, patients in 
the FO group demonstrated a higher overall mortality risk after adjustment for age, sex, systolic blood pressure, Charlson 
Original Article
Kidney Res Clin Pract 2020;39(4):414-425




Received May 27, 2020; Revised June 10, 2020; Accepted August 12, 2020
Editor: Jin Joo Cha, Korea University, Ansan, Republic of Korea
Correspondence: 
Jung Tak Park 
Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, 50 Yonsei-ro, 
Seodaemun-gu, Seoul 03722, Republic of Korea. E-mail: jtpark@yuhs.ac
Jung Pyo Lee
Department of Internal Medicine, Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 
07061, Republic of Korea. E-mail: nephrolee@gmail.com
*Jong Hyun Jhee and Jae Yoon Park contributed equally to this research.
Copyright © 2020 by The Korean Society of Nephrology 
CC  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc-nd/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly 
cited.
Jhee, et al. Cumulative fluid balance and mortality in the elderly
415www.krcp-ksn.org
Introduction
Continuous renal-replacement therapy (CRRT) has 
become an essential strategy for the management of 
critically ill patients with acute kidney injury (AKI) [1,2]. 
Previous research has identified several prognostic fac-
tors for mortality—including sepsis, higher Acute Physi-
ology and Chronic Health Evaluation (APACHE) II score, 
oliguria, higher Sequential Organ Failure Assessment 
(SOFA) score, and the need for mechanical ventilation—
in patients with severe AKI undergoing CRRT [3-6]. 
However, predicting the outcome of patients requiring 
CRRT remains a challenge. Recent studies have focused 
on the impact of cumulative fluid balance (CFB) on the 
outcomes of patients with severe AKI and have suggested 
that such could also be an important factor affecting out-
comes in this patient group [7-12].
Elderly patients are prone to AKI onset owing to their 
renal structural and functional alterations, multiple ac-
companying comorbidities, and polypharmacy [13-17]. 
Recent evidence suggests that the effect of fluid status on 
outcome might be different between elderly patients and 
the general population. Because of their decreased auto-
nomic function and reduced cardiovascular reserve, el-
derly patients undergoing CRRT are commonly exposed 
to the risk of overhydration. However, at the same time, 
the aforementioned factors may also cause elderly pa-
tients to be more susceptible to hydration-related com-
plications such as intradialytic hypotension and arrhyth-
mias. Moreover, changes in hydration status could result 
in alterations in serum electrolytes and osmolality, fur-
ther compromising the outcomes [18,19]. Nevertheless, 
few studies to date have specifically examined whether 
the CFB has a certain effect on elderly patients with AKI 
requiring CRRT.
In this study, through an analysis of a multicenter, pro-
spective CRRT cohort, the impact of CFB on mortality 




From a multicenter cohort (Seoul National University 
Hospital, Seoul National University Boramae Medical 
Center, and Severance Hospital), we initially screened a 
total of 1,471 adults (defined as those aged ≥ 18 years) in 
whom CRRT was initiated in the intensive care unit (ICU) 
because of AKI between August 2009 and December 
2013. Those who were aged younger than 65 years and 
who had undergone chronic maintenance dialysis were 
excluded; a total of 607 patients were finally analyzed. 
AKI was defined based on the Kidney Disease: Improv-
ing Global Outcomes clinical practice guidelines for AKI, 
as follows: an increase in serum creatinine by 0.3 mg/dL 
or more (≥ 26.5 µmol/L) within 48 hours, an increase in 
serum creatinine to at least 1.5 times the baseline value 
known or presumed to have occurred within the previ-
ous seven days, or a urine volume of less than 0.5 mL/
kg/hr for six hours. For the diagnosis of systemic inflam-
matory response syndrome, at least two of the following 
criteria were required: core temperature of either 38°C or 
greater or 36°C or less, heart rate of more than 90 beats/
min, respiratory rate of higher than 20 breaths/min, PCO2 
of 32 mmHg or less or mechanical ventilator use, and pe-
ripheral leukocyte count of either 12,000/mm3 or greater 
or 4,000/mm or less [20]. Septic AKI was defined as a sys-
temic inflammatory response syndrome combined with 
an infectious episode and AKI. The study subjects were 
divided into the fluid overload (FO) and no fluid overload 
(NFO) groups based on the median value of CFB during 
comorbidity index, Acute Physiology and Chronic Health Evaluation II score, serum albumin, creatinine, diuretic 
use, and mechanical ventilation status (hazard ratio, 1.38; 95% confidence interval, 1.13 to 1.89; P < 0.001). 
Among survivors, both the duration of CRRT and the total duration of hospitalization from CRRT initiation showed no 
difference between the FO and NFO groups.
Conclusion: A higher CFB value is associated with an increased risk of mortality in elderly patients with AKI requiring 
CRRT.
Keywords: Acute kidney injury, Aged, Continuous renal-replacement therapy, Cumulative fluid balance, Survival
Kidney Res Clin Pract   Vol. 39, No. 4, December 2020
416 www.krcp-ksn.org
72 hours before CRRT initiation. All included patients 
were followed up with until the time of death or hospital 
discharge. The study protocol complied with the Decla-
ration of Helsinki guidelines and received full approval 
from the Institutional Review Boards at Seoul National 
University Hospital, Seoul National University Boramae 
Hospital, and Severance Hospital. We obtained informed 
consent from the participants prior to their enrollment in 
the present study.
Data collection
The demographic and baseline clinical characteris-
tics of the enrolled patients were collected at the time 
of CRRT initiation, including age, sex, body mass index, 
cause of AKI, systolic blood pressure (SBP), diastolic 
blood pressure (DBP), mean arterial pressure (MAP), 
Charlson comorbidity index (CCI), and SOFA and 
APACHE II scores. In addition, the requirements for me-
chanical ventilation and the fraction of inspired oxygen 
were investigated, while the prescriptions for CRRT in-
cluding target clearance, dialysate flow rate, replacement 
flow rate, and use of anticoagulation were also assessed. 
Laboratory data were collected at the initiation of CRRT 
and the estimated glomerular filtration (eGFR) was cal-
culated using the Modification of Diet in Renal Disease 
equation [21].
The causes of AKI (i.e., septic, nephrotoxic, ischemic, 
postoperative, or other) were initially categorized based 
on a review of the electronic medical records performed 
by the researchers and confirmed by clinical diagnosis 
[22]. Nephrotoxic AKI was diagnosed as drug-induced 
AKI if offending drugs were administered within at least 
two weeks prior to the onset of AKI and if all other con-
tributing factors to AKI were absent. If more than one 
contributing factor was found to be occurring simultane-
ously, the major factors that had contributed to AKI were 
determined via clinical judgment rendered by research-
ers who were blinded to the clinical outcomes.
The initiation of CRRT and the prescription of CRRT 
settings were determined through consultations with 
nephrologists [23]. The criteria for CRRT initiation were 
medically intractable or persistent electrolyte imbalance, 
metabolic acidosis, decreased urine output with volume 
overload and/or progressive azotemia, and hemodynam-
ic instability in patients with a diagnosis of AKI. Gener-
ally, the vascular access for CRRT was established using 
a femoral venous catheter and the predilution method of 
continuous venovenous hemodiafiltration was adopted. 
To maintain CRRT adequacy after initiation, the attend-
ing physicians and experienced nurses monitored each 
patient’s body weight, urine output, laboratory results, 
actual delivered dose, and hemodynamic status and dis-
cussed the results with nephrologists.
Fluid status assessment and clinical outcomes
All available intake and output data for the 72 hours im-
mediately before CRRT initiation and the sum of this data 
were used to calculate the CFB. The input data included 
the amount of intravenous infusion of normal saline, dex-
trose, total parenteral nutrition, transfused material, or 
oral feedings. The output data included urine and other 
body fluids excreted from the catheter. The primary out-
come was all-cause mortality after CRRT initiation. The 
secondary outcomes were 28-day mortality after CRRT 
initiation, durations of CRRT and total renal-replacement 
therapy (RRT), and durations of ICU stay and total hospi-
talization from the initiation of CRRT.
Statistical analysis
The baseline characteristics of the groups were com-
pared using the independent t test for continuous vari-
ables and the chi-squared test for categorical variables, 
respectively. Continuous variables are presented as 
mean ± standard deviation and categorical variables 
are presented as numbers and percentages. After a test 
for normality, non-normally distributed variables were 
expressed as median (interquartile range) and were com-
pared using the Mann-Whitney U or Kruskal-Wallis 
test. Patient survival was estimated using Kaplan-Meier 
curves and multivariate Cox regression models based on 
the CFB findings during 72 hours before CRRT initiation. 
Propensity scores were estimated using multiple logistic 
regression analysis with adjustments for age, sex, CCI, 
SBP, and serum creatinine level. After calculating the pro-
pensity scores, we matched patients in the FO and NFO 
groups with similar propensity scores at a 1:1 ratio, us-
ing the nearest-neighbor method without replacements 
and with a 0.2-caliper width. Propensity score-matching 
(PSM) was used to increase the precision of the estimated 
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effect without increasing the bias resulting from the pres-
ence of variables potentially associated with survival [24]. 
The characteristics of both the FO and NFO groups were 
compared before and after PSM. Kaplan-Meier survival 
curves and life tables were generated for the two groups 
after PSM.
All statistical tests were conducted using a two-tailed 
95% confidence interval (CI) and a value of P < 0.05 was 
considered to be statistically significant. All descriptive 
and survival analyses were performed using the IBM 
SPSS ver. 25.0 for Windows software program (IBM Corp., 
Armonk, NY, USA). Meanwhile, the R ver. 3.1.0 software 
program (R Foundation for Statistical Computing, Vi-
enna, Austria) was used for PSM.
Sensitivity analyses
We adjusted the CFB by body weight at ICU admission 
to quantify the fluid overload percentage (FO%), which 
was defined as the percentage of fluid accumulation by 
dividing CFB in liters by patient’s body weight at ICU 
admission and multiplying by 100%. We divided subjects 
into high and low FO% groups based on the median value 
of FO% and adopted the groups as independent variables 
in multivariable Cox regression modeling for all-cause 
mortality.
We further performed subgroup analysis to stratify the 
mortality risk according to the causes of AKI (i.e., septic, 
nephrotoxic, ischemic, postoperative, and other) and the 
severity of disease based on the median value of APACHE 
II score (high vs. low).
Results
Baseline characteristics
The baseline characteristics of the study patients at 
CRRT initiation are presented in Table 1. The median age 
was 73.0 years and 60.0% of the patients were male. Sep-
sis (45.3%) was the most common cause of AKI, followed 
by ischemia (18.5%), postoperative complications (9.7%), 
and nephrotoxicity (7.4%), respectively. The median CFB 
value was 2,839.0 mL. As noted, the patients were divided 
into the FO (n = 303) vs. NFO (n = 304) groups according 
to the median CFB value of the total group (2,839.0 mL 
[1,892.1-4,631.8 mL]). Meanwhile, the median CFB value 
was 5,344.0 mL (3,784.0-7,274.0 mL) in the FO group 
and 1,028.5 mL (0.0-1,989.7 mL) in the NFO group. No 
differences were observed between the two groups with 
respect to the six-hour urine volume before CRRT initia-
tion or in dialysis parameters including target clearance, 
dialysate flow rate, replacement flow rate, and blood 
flow rate. The time from ICU admission to CRRT initia-
tion was 12.6 hours (1.9-50.7 hours) in the FO group 
and 3.9 hours (1.4-20.5 hours) in the NFO group (P < 
0.001). The CCI was higher in the NFO group, whereas 
the SOFA score, APACHE II score, and proportion of pa-
tients requiring mechanical ventilation were higher in 
the FO group (P < 0.001). Further, the SBP, DBP, and MAP 
were lower in the FO group and diuretic use was more 
frequent in the FO group. In the laboratory tests, the FO 
group showed lower serum creatinine and albumin lev-
els, hemoglobin values, and platelet counts but higher 
eGFR, aspartate aminotransferase levels, and alanine 
aminotransferase levels. The white blood cell count, pro-
thrombin time–international normalized ratio (PT-INR), 
and serum total bilirubin and blood urea nitrogen (BUN) 
levels were comparable between the two groups.
The patients in the two groups were matched using pro-
pensity scores for CFB levels, encompassing the following 
covariates: age, sex, CCI, SBP, and serum creatinine level. 
After PSM, a total of 520 patients (260 in each group) re-
mained. The propensity scores of the matched patients 
were not different between the two groups. Most baseline 
parameters, including age, sex, body mass index, CCI, 
SOFA score, SBP, DBP, MAP, six-hour urine volume before 
CRRT initiation, dialysis prescriptions, and biochemical 
data except for the PT-INR and serum total bilirubin level 
were comparable between the FO and NFO groups. How-
ever, in the FO group, time from ICU admission to CRRT 
initiation was shorter and the APACHE II score and rate 
of mechanical ventilation requirement or diuretic usage 
were higher than in the NFO group. Meanwhile, the PT-
INR, total bilirubin level, and creatinine level were lower 
in the FO group than in the NFO group.
Association between CFB and all-cause mortality
A total of 490 (79.2%) deaths occurred during the medi-
an follow-up period of 9.6 days. Fig. 1 shows the Kaplan–
Meier curves for survival rates between the FO and NFO 
groups before (A) and after (B) PSM. The risk of all-cause 
Kidney Res Clin Pract   Vol. 39, No. 4, December 2020
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Table 1. Baseline characteristics before and after PSM
Characteristic
Before PSM After PSM
FO (n = 303) NFO (n = 304) P value FO (n = 260) NFO (n = 260) P value




































Cause of acute kidney injury < 0.001 0.025




























































SOFA score 12.9 ± 3.4 11.1 ± 3.4 < 0.001 11.9 ± 3.4 11.8 ± 4.0 0.740
APACHE II score 30.2 ± 7.5 27.9 ± 6.9 < 0.001 27.8 ± 6.9 29.9 ± 7.3 < 0.001


















Systolic blood pressure (mmHg) 110.2 ± 23.9 114.2 ± 25.7 0.048 111.3 ± 23.2 111.9 ± 23.7 0.760
Diastolic blood pressure (mmHg) 59.5 ± 14.0 63.2 ± 14.8 < 0.001 59.7 ± 13.9 62.5 ± 14.4 0.022
Mean arterial pressure (mmHg) 76.4 ± 15.2 80.2 ± 16.5 < 0.001 76.1 ± 14.4 78.9 ± 15.4 0.121
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mortality was significantly lower in the FO group than in 
the NFO group. This result remained consistent after PSM 
(P < 0.001). Multivariable Cox proportional-hazards analysis 
was also performed with or without PSM (Table 2). Before 
PSM, the FO group showed an increased risk of mortality 
in the univariable model (model 1) (hazard ratio [HR], 
Table 1. Continued
Characteristic
Before PSM After PSM
FO (n = 303) NFO (n = 304) P value FO (n = 260) NFO (n = 260) P value
Biochemical data




































    Albumin (g/dL) 2.6 ± 0.6 2.8 ± 0.5 < 0.001 2.7 ± 0.5 2.6 ± 0.5 0.101


























































The data are presented as median (interquartile range), number (percentage), or as mean ± standard deviation.
APACHE II, Acute Physiology and Chronic Health Evaluation II; CRRT, continuous renal-replacement therapy; eGFR, estimated glomerular filtration rate; FiO2, inspired 
oxygen fraction; FO, fluid overload; ICU, intensive care unit; NFO, no fluid overload; PT-INR, prothrombin time–international normalized ratio, PSM, propensity score-
matching; SD, standardized difference; SOFA, Sequential Organ Failure Assessment.
Figure 1. Kaplan-Meier curves for all-cause mortality compared between the fluid overload (FO) and no fluid overload (NFO) 
groups before (A) and after (B) propensity score-matching.
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1.74; 95% CI, 1.45-2.08; P < 0.001). This association was 
significant after adjustment for age, sex, and CCI (model 
2) (HR, 1.71; 95% CI, 1.42-2.05; P < 0.001) or for SBP, 
serum albumin and creatinine levels, APACHE II score, 
use of diuretics, mechanical ventilation status (model 3) 
(HR, 1.38; 95% CI, 1.13-1.89; P < 0.001). Moreover, this 
association remained significant after PSM (model 4) (HR, 
1.59; 95% CI, 1.31-1.94; P < 0.001). The 28-day cumulative 
survival was lower in the FO group (P < 0.001; Fig. 2A), and 
this trend also remained significant after PSM (P < 0.001; 
Fig. 2B).
Duration of RRT and hospitalization
Before PSM, the duration of CRRT was 3.1 days (1.3-6.2 
days) in the FO group and 3.4 days (1.4-6.9 days) in the 
NFO group (P = 0.287; Table 3). The duration of total RRT 
and the total duration of hospitalization were shorter in the 
FO group (3.4 and 7.2 days, respectively) than in the NFO 
group (4.7 and 17.8 days, respectively) (P = 0.032 and P < 
0.001, respectively). However, among the survivors, no 
differences were observed in the duration of CRRT, total 
RRT, ICU stay, or hospitalization between the FO and 
NFO groups.
After PSM, no significant difference was found in the 
duration of CRRT or total RRT between the total study 
group and the survivors. The duration of ICU stay from 
CRRT initiation was also not different between the two 
groups. However, although the total duration of hospi-
talization was shorter in the FO group, no difference was 
observed among the survivors of the two groups.
Sensitivity analyses
We further conducted an analysis using the adjusted 
CFB by body weight at ICU admission (FO%). Both a mul-
tivariable Cox analysis for all-cause mortality and a PSM 
analysis were performed and the results were consistent 
with the main findings that subjects with high FO% expe-
rienced an increased risk of mortality as compared with 
those with low FO% (Table 4).
In addition, we stratified the risk according to causes 
Table 2. The risk for all-cause mortality between the FO and NFO groups
Group
Model 1a Model 2b Model 3c Model 4d
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
NFO 1.00 (reference)  1.00 (reference) 1.00 (reference) 1.00 (reference)
FO 1.74 (1.45-2.08) < 0.001 1.71 (1.42-2.05) < 0.001 1.38 (1.13-1.89) < 0.001 1.59 (1.31-1.94) < 0.001
CI, confidence interval; FO, fluid overload; HR, hazard ratio; NFO, no fluid overload.
aUnadjusted model. bAdjusted for age, sex, and Charlson comorbidity index (CCI). cModel 2 + systolic blood pressure (SBP), serum albumin, creatinine, Acute 
Physiology and Chronic Health Evaluation II score, use of diuretics, and mechanical ventilation status. dPropensity score-matched; covariates for matching: age, sex, 
CCI, SBP, and serum creatinine level.
Figure 2. Kaplan-Meier curves for 28-day mortality compared between the fluid overload (FO) and no fluid overload (NFO) groups 
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of AKI (septic, nephrotoxic, ischemic, postoperative, 
and other) and the severity of disease according to the 
APACHE II score (high vs. low based on the median 
value). The subgroups and fluid status showed no inter-
action with mortality, suggesting that the relationship 
between CFB and outcome remained regardless of AKI 
cause and patient severity (Fig. 3).
Discussion
In this study, we compared the survival rates between 
the FO and NFO groups based on CFB assessed at 72 
hours before CRRT initiation in elderly patients undergo-
ing CRRT because of AKI. In the FO group, the risks of all-
cause mortality and 28-day mortality were significantly 
higher than those in the NFO group. These results were 
consistent after the PSM analysis. Among survivors, the 
duration of CRRT or hospitalization showed no differ-
ence between the FO and NFO groups. These results 
indicate that the risk of mortality increases according to 
the amount of fluid used for resuscitation prior to CRRT 
initiation.
Previous studies have identified prognostic factors for 
mortality in patients with severe AKI requiring RRT. In 
the early 2000s, several study groups found that continu-
ous and intensive RRT was related to a lower mortal-
ity risk than intermittent hemodialysis in patients with 
AKI [25,26]. Several years later, an observational cohort 
study investigated the prognostic factors of critically ill 
patients treated with CRRT in the ICU [4]. A more recent 
investigation of 197 patients requiring CRRT initiation 
in the ICU setting identified three independent factors 
associated with fatal outcomes (mechanical ventilation 
requirement, sepsis, and septic shock requiring vasoac-
tive agents) and two factors associated with favorable 
outcomes (nonoliguric AKI and low serum creatinine 
levels). Finally, several study groups have attempted to 
identify more reliable prognostic factors associated with 
worse outcomes in patients with AKI, including disease 
severity assessed according to the APACHE II or SOFA 
score, amount of urine output, serum BUN level, timing 
of CRRT, and previous health status [3-6,27-29]. Despite 
improvements in the knowledge of such prognostic fac-
tors in patients requiring CRRT, the mortality rate of pa-
tients with AKI treated with CRRT remains high, reaching 
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about which factor could best predict clinical outcomes. 
In this regard, it is difficult to conclude that the prognos-
tic factors in patients with AKI requiring CRRT have been 
completely identified. Therefore, there is considerable 
interest in developing novel management strategies for 
reducing the mortality rate.
Recently, several studies have reported that FO dur-
ing the ICU stay could be an important prognostic fac-
tor for predicting mortality in patients with AKI treated 
with CRRT [7-12]. Fluid administration is inevitable in 
ICU patients with septic shock or AKI; however, fluid 
resuscitation may enhance filling pressure and improve 
microcirculation in these conditions [9,32]. Nevertheless, 
several studies focused on the undesirable effects of fluid 
administration and demonstrated that a positive mean 
daily fluid balance was associated with increased mor-
tality in patients with AKI treated in the ICU. One study 
group found that a positive fluid balance was associated 
with a higher risk of mortality in ICU patients with AKI 
[11], while another study similarly confirmed the associa-
tion of higher fluid balance with mortality in ICU patients 
with AKI [33]. These studies reported a higher mean fluid 
balance existed in nonsurvivors than in survivors during 
the first seven days of ICU stay. However, both studies 
had several limitations. First, both study groups included 
patients with AKI regardless of CRRT initiation. Because 
the fluid status might be different between patients with 
and without CRRT, respectively, the analysis of these 
populations should be performed separately. Also, the 
latter study included only 132 participants with AKI and 
the definition of AKI used for inclusion in the analysis 
was based on a serum creatinine level of 3.5 mg/dL or 
higher or a urine output of less than 500 mL/day, without 
the use of a baseline serum creatinine level to assess the 
absolute or relative changes in serum creatinine. More-
over, both studies defined fluid status as the mean value 
of daily fluid balance and, importantly, the use of this 
value could cause miscalculation or underestimation of 
the exact fluid status. It is crucial to define FO by using a 
decisive rather than arbitrary method.
CFB is defined as the net fluid that accumulates during 
the first 72 hours of CRRT or the ICU stay [7]. This defini-
tion is widely accepted and provides clinically valuable 
information to help make risk stratification more uni-
form among critically ill patients, with CFB incorporated 
as an additional clinical parameter [12]. An observational 
study that investigated 618 ICU patients with AKI evalu-
ated the association between FO and mortality as well as 
Table 4. The risk for all-cause mortality between high vs. low FO% groups
Variable
Model 1a Model 2b Model 3c Model 4d
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Low FO% 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
High FO% 1.76 (1.47–2.12) < 0.001 1.75 (1.46–2.10) < 0.001 1.42 (1.16–1.74) 0.001 1.69 (1.40–2.064) < 0.001
FO% was defined by the percentage of fluid accumulation by dividing CFB in liters by the patient’s body weight at ICU admission and multiplying by 100%.
CI, confidence interval; FO%, fluid overload percentage; HR, hazard ratio.
aUnadjusted model. bAdjusted for age, sex, and Charlson comorbidity index (CCI). cModel 2 + systolic blood pressure (SBP), serum albumin, creatinine, Acute 
Physiology and Chronic Health Evaluation II score, use of diuretics, and mechanical ventilation status. dPropensity score-matched; covariates for matching: age, sex, 
CCI, SBP, and serum creatinine level.
Figure 3. Subgroup analysis stratified 
by causes of acute kidney injury (AKI) 
and severity of disease. APACHE II, 
Acute Physiology and Chronic Health 
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the recovery of kidney function [10]. The authors defined 
FO as an increase of more than 10% in CFB adjusted for 
body weight relative to baseline and reported that FO was 
significantly related to a higher risk of mortality, not to 
kidney function recovery. Notably, these authors stud-
ied large numbers of patients and obtained well-defined 
measurements of fluid status; however, the study groups 
were heterogeneous, as half of the patients were treated 
with CRRT and half were treated without CRRT. Later 
studies found that a higher CFB at the time of dialysis 
initiation for AKI was associated with mortality [34] and 
worse renal recovery [35]. One prospective, multicenter, 
observational study evaluated the association between 
FO at RRT initiation and mortality in 283 critically ill 
patients with AKI and reported that CFB was associated 
with an increased risk of 90-day mortality [34]. Another 
study showed that FO could predict worse renal recovery 
in hospitalized patients with AKI requiring RRT [35]. In 
this single-center study with 170 subjects, CFB was a sig-
nificant negative predictor of renal recovery. These stud-
ies evaluated the negative effect of FO on worse outcomes 
in critically ill patients with AKI, yet the population sizes 
of these studies were relatively small. Moreover, the age 
group, which is one of the most important prognostic fac-
tors for clinical outcomes in patients with AKI, was het-
erogeneous.
The elderly population, which includes individuals 
aged 65 years or older, is rapidly growing in developed 
countries alongside an increase in the global life expec-
tancy [36]. In accordance with the increasing size of the 
elderly population, the incidence of AKI is also rising 
[15,37,38]. Elderly people have a higher tendency to de-
velop AKI because of structural or functional alterations 
in the kidneys, the presence of multiple comorbidi-
ties (e.g., arteriosclerosis, hypertension, diabetes mel-
litus, and heart failure), and resultant medication use 
[13,14,39]. Thus, the elderly population is less able to 
adapt to rapid hemodynamic changes and alterations in 
electrolyte levels and osmolarity [16,17,40]. Furthermore, 
maintaining a stable fluid balance is difficult for elderly 
patients. Finally, the importance of fluid balance might 
be as essential for elderly individuals as it is for the gen-
eral population. To our knowledge, this study is the first 
to investigate the association between CFB and mortality 
among elderly patients with AKI treated with CRRT. This 
study has strength in that it included 607 elderly patients 
with AKI requiring CRRT and evaluated large numbers of 
patients with equivalent treatment conditions. Further, a 
PSM analysis with more than 400 patients was addition-
ally performed.
However, this study also has several limitations. First, 
because of its observational design, the causality be-
tween FO and worse clinical outcomes cannot be clearly 
determined. Fluid itself, as is true with any medication 
used in ICU care, may have harmful effects, which could 
indicate that the association between FO and mortality is 
largely secondary. Randomized controlled studies should 
be performed to overcome this limitation. Second, there 
was no benefit of lower CFB on the duration of RRT or 
hospitalization, which was more evident as a result after 
PSM analysis. We assumed that because patients with FO 
obviously showed shorter survival days, they also dem-
onstrated shorter durations of RRT and hospitalization 
relative to patients with NFO. Third, although we adjust-
ed for various confounding factors using multivariable 
analyses, residual confounding by unmeasured covari-
ates may not have been completely eliminated. However, 
we performed a PSM analysis to overcome this limitation. 
Finally, our results do not allow us to define the appro-
priate amount of fluid. Despite the adverse effects of FO 
on clinical outcomes, determining the optimal amount of 
fluid administration remains a challenge in ICU care, es-
pecially in elderly patients with AKI. Thus, further studies 
are warranted to identify a clear target amount of fluid 
administration so as to minimize the negative effects and 
maximize the benefits of fluid management.
In conclusion, an increasing CFB is associated with an 
increased risk of mortality in elderly patients with AKI 
requiring CRRT. Our study results emphasize that close 
observation of the fluid balance is important and that use 
a large amount of fluid for resuscitation before CRRT can 
result in poor survival in elderly patients with AKI.
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